The role of protein kinase C in the pathophysiology of diabetic retinopathy;Die bedeutung der proteinkinase C in der pathophysiologie der diabetischen retinopathie

Klinische Monatsblatter fur Augenheilkunde

Volumn 219, Issue 11, 2002, Pages 769-776

  Lang, Gabriele E ^a   Kampmeier, Jürgen ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Diabetic retinopathy; Diacylglycerol (DAG); LY333531; PKC isoenzymes; Protein kinase C (PKC); Vitamin E

Indexed keywords

DIACYLGLYCEROL; GLUCOSE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN;

CELL PROLIFERATION; CLASSIFICATION; DIABETIC RETINOPATHY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

BLOOD GLUCOSE; DIABETIC RETINOPATHY; ENZYME ACTIVATION; HUMANS; ISOENZYMES; PROTEIN KINASE C;

EID: 0036872243     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36328     Document Type: Review

References (102)

1. Aiello LP, Bursell SE, Clermont A et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46: 1473-1480
2. Aiello LP, Gardner TW, King GL et al. Diabetic retinopathy (technical review). Diabetes Care 1998; 21: 143-156
3. Aiello LP, Robinson GS, Lin YW et al. Identification in multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA 1994; 91: 6231-6235
4. Andrea JE, Walsh MP. Protein kinase C of smooth muscle. Hypertension 1992; 20: 585-595
5. Avignon A, Yamada K, Zhou X et al. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type 11 diabetic Goto-Kakizaki (GK), obese/aged, and obese Zucker rats. Diabetes 1996; 45: 1396-1404
6. Ayo SH, Radnik RA, Garoni J et al. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990; 138: 1339-1348
7. Ayo SH, Radnik RA, Glass WF et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am J Physiol 1991; 260: 185-191
8. Bahr M, Spenlieken M, Bock M et al. Acute and chronic effects of troglitazone on isolated rat ventricular cardiomyocytes. Diabetologica 1996; 39: 766-774
9. Bandyopadhyay G, Standaert M, Galloway L et al. Evidence for involvement of protein kinase C (PKC)-ξ and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 1999; 138: 4721-4731
10. Berti L, Mosthaf L, Kroder G et al. Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem 1994; 269: 3381-3386
11. Blackmore PF, Strickland WG, Exton JH. Phosphorylation of glycogen synthase by protein kinase C. Biochem J 1986; 237: 235-242
12. Boggs KP, Farese RV, Buse MG. Insulin administration in vivo increases 1,2-diacylglycerol in rat skeletal muscle. Endocrinology 1991; 128: 636-638
13. Bollag GB, Roth RA, Beaudoin J et al. PKC directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 1986; 83: 5822-5824
14. 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993; 42: 1673-1677
15. Boneh A. Possible role of protein kinase C in the pathogenesis of inborn errors of metabolism. J Cell Biochem 1995; 59: 27-32
16. Bursell SE, Clemont AC, Aiello LP et al. High-dose vitamin E supplementation normalises retinal blood flow and creatinine clearance in patients with type-1 diabetes. Diabetes Care 1999; 22: 1245-1251
17. Busch AK, Castan I, Degerman E et al. Protein kinase C mediates hyperglycaemia-induced insulin resistance through serine phosphorylation of IRS-1. Diabetologica 1998; 41: 10
18. Cagliero E, Roth T, Roy S et al. Expression of genes related the extracellular matrix in human endothelial cells. Biol Chem 1991; 266: 14244-14250
19. Cagliero E, Roth T, Roy S et al. Characteristics and mechanisms of high glucose-induced overexpression of basement membrane components in cultured endothelial cells. Diabetes 1991; 40: 102-110
20. Carlin S, Yang KXF, Donnelly R, Black JL. Protein kinase C isoforms in human airway smooth muscle cells - A role for PKC-ξ in proliferation. Am J Physiol 1999; 276: 506-512
21. Castagna M, Takai Y, Kaibuchi K et al. Direct activation of calciumactivated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847-7851
22. Caukai M, Molchy-Rosen D. Pharmacologic modulation of protein kinase isoforms: the role of RACKs and subcellular localization. Pharmacol Res 1999; 39: 253-259
23. Chakravarthy U, Hayes R, Stitt A et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end-products. Diabetes 1998; 47: 945-952
24. Chiu R, Boile WJ, Meek J et al. The c-Fos protein interacts with C-Jun/AP-1 responsive genes. Cell 1988; 54: 541-552
25. Considine RV, Nyce MR, Allen LE et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycaemia. J Clin Invest 1995; 95: 2938-2944
26. Cortright RN, Muoio DM, Dohm GL. Skeletal muscle lipid metabolism: a frontier for new insights into fuel homeostasis. Nut Biochem 1997; 8: 228-245
27. Craven PA, Davidson CM, DeRubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990; 39: 667-674
28. Cunha-Vaz JG. Vitreous fluorometry. In: Osborne MN, Ghader (eds): Progress in Retinal Research. Oxford: Pergamon Press, 1985: 90-114
29. Danis RP, Bingaman DP, Jirousek M et al. Inhibition of intraocular neovascularisation caused by retinal ischaemia in pigs by PKC-β inhibition with LY333531. Invest Ophthalmol Vis Sci 1998; 39: 171-179
30. Diabetic Retinopathy Study Research Group. Report 8: Photocoagulation treatment of proliferative diabetic retinopathy: Clinical applications of Diabetic Retinopathy Study (DRS) findings. Ophthalmology 1981; 88: 583-600
31. Donnelly R, Reed MJ, Azhar S, Reaven GM. Expression of the major isoenzyme of protein kinase C in skeletal muscle, PKC-Θ, varies with muscle type and in response to fructose-induced insulin resistence. Endocrinology 1994; 135: 2369-2374
32. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number One. Arch Ophthalmolol 1985; 103: 1796-1806
33. II. J Biol Chem 1999; 274: 6461-6468
34. Fabbro D, Ruetz S, Bodis S et al. KC412 - a protein kinase inhibitor with a broad therapeutic potential. Anti-Cancer Drug Design 2000; 15: 17-28
35. 1 transcriptional activity in a reporter mesangial cell line. Am J Physiol 1994; 267: 632-638
36. Gabriele A, King GL. Proteinkinase C inhibitors in the treatment and prevention of diabetic complications. Curr Opin Endocrinol Diabet 2001; 8: 197-204
37. Geschwendt M. Protein kinase C delta. Eur J Biochem 1999; 259: 555-564
38. Goekjian PE, Jirousek M. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 1999; 6: 877-903
39. A receptor subtype. Metabolism 2000; 49: 264-269
40. Griffin ME, Marcucci MJ, Cline GW et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C-Θ and alterations in the insulin signalling cascade. Diabetes 1999; 48: 1270-1274
41. Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1995; 241: 42-52
42. Hayashi A, Seki N, Hattori A et al. PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochem Biophys Acta 1999; 1450: 99-106
43. Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 1997; 273: 2442-2451
44. Hunter T. Signaling - 2000 and beyond. Cell 2000; 100: 113-127
45. Idris I, Gray S, Donnelly R. Protein kinase C aktivation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologica 2001; 44: 659-673
46. II and diacylglycerol levels in aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992; 89: 11056-11063
47. Inoue M, Kishimoto A, Takai Y, Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 1977; 252: 7610-7616
48. Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC-β inhibitor. Science 1996; 272: 728-731
49. Itani SI, Zhou Q, Pories WJ et al. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000; 49: 1353-1358
50. Jamora C, Yamanouye N, van Lint J et al. Gβγ-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 1999; 98: 59-68
51. Johnson JE, Giorgione J, Newton AC. The C1 and C2 domains of protein kinase C are independent membrane targeting modules, with specifity for phosphatidylserine conferred by the C1 domain. Biochemistry 2000; 39: 11360-11369
52. Kishimoto A, Takai Y, Mori T et al. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 1980; 255: 2273-2276
53. 2. Proc Natl Acad Sci USA 1997; 94: 11233-11237
54. Kowluru RA, Jrousek MR, Stramm L et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPase. Diabetes 1998; 47: 464-469
55. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-866
56. Koya D, Lee IK, Ishii H et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 1997; 8: 426-435
57. Kreuzer J, Denger S, Schmidts A et al. Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism. J Mol Med 1996; 74: 161-165
58. Kunisaki M, Bursell SE, Clermont AC et al. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 1995; 269: 239-246
59. Kunisaki M, Bursell SE, Umeda F et al. Normalisation of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 1994; 43: 1372-1377
60. Kunisaki M, Fumio U, Nawata H et al. Vitamin E normalises diacylglycerol-protein kinase C activation induced by hyperglycaemia in rat vascular tissues. Diabetes 1996; 45: 117-119
61. Li P-F, Maasch C, Haller H et al. Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. Circulation 1999; 100: 967-973
62. Liao D-F, Monia B, Dean N et al. Protein kinase C-ζ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997; 272: 6146-6150
63. Liu WS, Heckman CA. The sevenfold way of PKC regulation. Cell Signal 1998; 10: 529-542
64. Lu X, Yang X-Y, Howard RL, Walsh JP. Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis. Diabetologica 2000; 43: 1136-1144
65. Malhotra A, Reich D, Nakouzi A et al. Experimental diabetes is associated with functional acitivation of protein kinase C epsilon and phosphorylation of troponin-I in the heart, which are prevented by angiotensin II receptor blockade. Circ Res 1997; 81: 1027-1033
66. Mischak H, Goodnight JA, Kolch W et al. Overexpression of protein kinase C ™ and Σ, in NIH 3T3 cells induces opposite effects of growth, morphology, anchorage dependence, and tumorgenicity. J Biol Chem 1993; 268: 6090-6096
67. Molchy-Rosen D, Wu G, Hahn H et al. Cardiotrophic effects of protein kinase C: analysis by in vivo modulation of PKC translocation. Circ Res 2000; 86: 1173-1179
68. Mosthaf L, Busch AK, Juhl LF et al. The insulin receptor is degraded by specific PKC isoforms. Diabetologica 1998; 41: 10
69. Muller HK, Kellerer M, Ermel B et al. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes 1991; 40: 1440-1448
70. Murphy M, Godson C, Cannon S et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274: 5830-5834
71. Newton AC. Protein kinase C: structure, function and regulation; minireview. J Biol Chem 1995; 270: 28495-28498
72. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9: 484-496
73. Nishizuka Y. The molecular etherogeneity of protein kinase C and its implication for cellular regulation. Nature 1988; 334: 661-665
74. Park J-Y, Takahara N, Gabriele A et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 2000; 49: 1239-1248
75. Phillips DIW, Caddy S, Iiic V et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non-diabetic subjects. Metabolism 1996; 45: 947-950
76. Pillay TS, Xiao S, Olefsky IM. Glucose-induced phosphorylation on the insulin receptor. J Clin Invest 1996; 97: 613-620
77. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105: 32-39
78. Riser BL, Denichilo M, Cortes P et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000; 11: 25-38
79. Ron D, Kazanietz MB. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999; 13: 1658-1676
80. Schmitz-Peiffer C, Browne CL, Oakes ND et al. Alterations in the expression and cellular localisation of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat fed rat. Diabetes 1997; 46: 169-178
81. Sharma K, Jin Y, Guo J at al. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-530
82. Shiba T, Inoguchi T, Sportsman JR et al. Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 1993; 265: 783-793
83. Shmueli E, Alberti KGM, Record CO. Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? J Intern Med 1993; 234: 397-400
84. Spiro MJ, Crowley TJ. Increased rat myocardial type VI collagen in diabetes mellitus and hypertension. Diabetologica 1993; 36: 93-96
85. Standaert ML, Galloway L, Karnam P et al. Protein kinase C-ξ as a down-stream, effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. J Biol Chem 1997; 272: 30075-30082
86. Standl E, Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologica 2000; 43: 1455-1469
87. Stasek JE, Patterson C, Garcia JGN. Protein kinase C phosphorylates caldesmon-77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial monolayers. J Cell Physiol 1992; 153: 62-75
88. Storlein LH, Borkman M, Jenkins AB et al. Diet and in vivo insulin action: of rats and man. Diabetes Nutr Metab 1991; 4: 227-240
89. Takagi C, Bursell SE, Lin Y-W et al. Regulation of retinal heamodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 1996; 37: 2504-2518
90. Takai Y, Kishimoto A, Iwasa Yet al. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 1979; 254: 3692-3695
91. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
92. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
93. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001; 18: 945-959
94. Williams B, Gallacher B, Patel H et al. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997; 46: 1497-1503
95. Williams B, Schrier RW. Characterisation of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 1992; 41: 1464-1472
96. Williams B. Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hyperten 1995; 13: 477-486
97. Williamson JR, Kilo C. Extracellular matrix changes in diabetes mellitus. In: Scarpelli DG, Migahi G (eds): Comparative pathobiology of major age-related disease. NY: Liss, 1984: 269-288
98. Xia P, Aiello LP, Ishii H et al. Characterisation of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996; 98: 2018-2026
99. Xia P, Inoguchi T, Kern TS et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994; 43: 1122-1129
100. Yazaki T, Ahmad S, Chahlavi A et al. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide. Mol Pharmacol 1996; 50: 236-242
101. Yu W, Niwa T, Fukasawa T et al. Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta cell. Diabetes 2000; 49: 945-952
102. Ziyadeh FN, Sharma K, Ericksen M et al. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 1994; 93: 536-542